Inadequate and Delayed Characterization of Cutaneous Reactions for FDA Approved Oncologic Drugs from 2011–2020 Leading to Medication Discontinuation

Published: 25-09-2020| Version 1 | DOI: 10.17632/stjkfxhbkh.1
Contributor:
Jason Yang

Description

Supplemental data for JAAD publication

Files